These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2861914)

  • 1. Stereoselectivity in the metabolism of the beta-adrenergic blocking agent, (+/-)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man.
    Honma S; Ito T; Kambegawa A
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):760-8. PubMed ID: 2861914
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stereoselective glucuronidation of beta-blocking agents, 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32) and propranolol, in animals, in vivo and in vitro].
    Honma S; Ito T; Matsuki Y
    Yakugaku Zasshi; 1986 May; 106(5):406-13. PubMed ID: 2876088
    [No Abstract]   [Full Text] [Related]  

  • 3. [The metabolism of 1-tertiary-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32), a new beta-blocker agent. II. Blood level, distribution, and structure of its metabolites in bile (author's transl)].
    Honma S; Kanbekawa A
    Yakugaku Zasshi; 1975 Jun; 95(6):680-9. PubMed ID: 241825
    [No Abstract]   [Full Text] [Related]  

  • 4. Esmolol: a pharmacokinetic profile of a new cardioselective beta-blocking agent.
    Yacobi A; Kartzinel R; Lai CM; Sum CY
    J Pharm Sci; 1983 Jun; 72(6):710-1. PubMed ID: 6135794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man.
    Morita S; Iinuma M; Kido M; Sakuragi S; Kohri H; Nishino H
    Arzneimittelforschung; 1977; 27(12):2380-3. PubMed ID: 23800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of metabolites derived from 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32), a new beta-blocker.
    Honma S; Kambekawa A
    Chem Pharm Bull (Tokyo); 1975 May; 23(5):1045-56. PubMed ID: 241494
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ocular tissue distributions of befunolol hydrochloride, a beta-adrenergic blocking agent, after intravitreous or subconjunctival injection into the albino and pigmented rabbits].
    Ishii Y; Matsumura Y; Shirasawa E; Araie M
    Nippon Ganka Gakkai Zasshi; 1984 Oct; 88(10):1278-86. PubMed ID: 6151807
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on cardiovascular drugs. 8. Metabolism of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].
    Nakanishi M; Kato Y; Arima N
    Yakugaku Zasshi; 1972 Mar; 92(3):299-304. PubMed ID: 4403111
    [No Abstract]   [Full Text] [Related]  

  • 9. [The metabolism of the beta receptor blocker talinolol in humans--relationship between structure, polarity and amount excreted].
    Oertel R; Richter K
    Pharmazie; 1995 Sep; 50(9):637-8. PubMed ID: 7480105
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
    Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of 5-(3-tert-butylamino-2-hydroxypropoxy)-8-hydroxy-3,4-dihydrocarbostyril hydrochloride and its beta-adrenergic blocking activity].
    Uchida M; Tominaga M; Oka K; Tone H; Uno T
    Yakugaku Zasshi; 1976 May; 96(5):571-7. PubMed ID: 9501
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic studies on CS-359, a new beta-adrenergic blocking agent. I. Isolation and identification of the urinary metabolites of CS-359.
    Hayashi R; Okada M; Nakazawa T; Tanaka Y; Shimoji Y
    Chem Pharm Bull (Tokyo); 1975 Jun; 23(6):1173-83. PubMed ID: 241498
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).
    Goldaniga G; Montesanti L; Pianezzola E; Valzelli G
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):9-20. PubMed ID: 6104601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in the metabolism of pamatolol, a cardioselective beta--adrenoceptor antagonist.
    Hoffmann KJ; Skånberg I; Borg KO
    Eur J Drug Metab Pharmacokinet; 1979; 4(3):163-73. PubMed ID: 43252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of flestolol in man: preliminary data.
    Achari R; Hulse JD; Drissel D; Matier WL
    Br J Clin Pharmacol; 1985 Dec; 20(6):691-4. PubMed ID: 2868745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of the route of administration on the metabolism of a beta-adrenergic blocker, o-[3-(tert-butylamino)-2-hydroxypropoxy]-benzonitrile (bunitrolol) (author's transl)].
    Rikihisa T; Toyama S; Mori M; Suzuki T
    Yakugaku Zasshi; 1978 Sep; 98(9):1258-66. PubMed ID: 32380
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of beta-adrenoceptors on rat skeletal muscle cells grown in vitro.
    Disatnik MH; Sampson SR; Shainberg A
    Biochem Pharmacol; 1990 Sep; 40(5):1043-8. PubMed ID: 1975171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of tertatolol enantiomers in biological fluids by high-performance liquid chromatography.
    Lave T; Efthymiopoulos C; Koffel JC; Jung L
    J Chromatogr; 1991 Dec; 572(1-2):203-10. PubMed ID: 1687817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid analysis for metabolites of 11C-labelled drugs: fate of [11C]-S-4-(tert.-butylamino-2-hydroxypropoxy)-benzimidazol-2-one in the dog.
    Jones HA; Rhodes CG; Law MP; Becket JM; Clark JC; Boobis AR; Taylor GW
    J Chromatogr; 1991 Oct; 570(2):361-70. PubMed ID: 1686775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.
    Regårdh CG; Borg KO; Johansson R; Johnsson G; Palmer L
    J Pharmacokinet Biopharm; 1974 Aug; 2(4):347-64. PubMed ID: 4155762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.